Tandem Diabetes Care, Inc. Defined Contribution Plan, Cost
Tandem Diabetes Care, Inc. (TNDM) reported Defined Contribution Plan, Cost of $4.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-19
- Tandem Diabetes Care, Inc. defined contribution plan, cost for fiscal 2025 was $4.90M, a 6.52% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. defined contribution plan, cost for fiscal 2024 was $4.60M, a 9.52% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. defined contribution plan, cost for fiscal 2023 was $4.20M, a 0.00% change from fiscal 2022.
- Tandem Diabetes Care, Inc. defined contribution plan, cost for fiscal 2022 was $4.20M.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $4.90M 10-K · filed 2026-02-19 |
| 2024-12-31 | $4.60M 10-K · filed 2026-02-19 |
| 2023-12-31 | $4.20M 10-K · filed 2026-02-19 |
| 2022-12-31 | $4.20M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |